Death receptors are involved in various diseases, particularly those related to the immune system and cancer. In cancer, the dysregulation of death receptor pathways can lead to uncontrolled cell proliferation and resistance to apoptosis, making them targets for therapeutic agents. In autoimmune diseases, inappropriate activation of death receptors can lead to excessive cell death, contributing to tissue damage and disease progression.
